The Financial Ombudsman Service (FOS) has rejected five out of 43 claims at decision stage against advice to invest in Arch Cru since it started publishing complaints decisions last April, its data has shown.

Standard Life Investments' head of global equities David Cumming has said the group has finally lost patience with banks over bonuses, prompting last week's shock decision to publicly oppose Barclays' remuneration plans.

Former New Star manager Patrick Evershed has reportedly been jeered at Barclays' AGM today after attempting to defend the bank's bonus proposals.

Standard Life Investments has taken the unusual step of criticising Barclays during its AGM, attacking the bank over its latest remuneration proposals amid a fiery meeting.

Alan Custis and Alan Clifford have stuck with insurers amid early signs the sector is rebounding from the sharp falls sparked by Chancellor George Osborne's move to change the pensions landscape.

The UK's ongoing recovery from one of its worst spells for decades could give the Chancellor room to cut taxes by £7bn in 2015, a leading consultancy has said.

GlaxoSmithKline, the UK's largest pharmaceutical group, and rival AstraZeneca, saw shares jump sharply - with the latter up 10% - as a series of deals in the sector boosted prices.

Google shares moved sharply lower in after-hours trading following a disappointing update, with the negative sentiment that has blighted the sector showing no sign of abating.

Towry's chief executive Andrew Fisher is to leave the firm, with former Prudential UK chief Rob Devey to take over the role.

The FTSE 100 was down nearly 1% this morning, while gold was in the ascendency, as investors sold down BP amid the latest developments in Ukraine.